We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Peptoids that Mimic Antigen Shapes May Lead to a New Generation of Diagnostic Tests

By LabMedica International staff writers
Posted on 22 Jun 2016
Print article
Image: The molecular structure of a peptoid helix (Photo courtesy of The Peptoid Summit).
Image: The molecular structure of a peptoid helix (Photo courtesy of The Peptoid Summit).
A novel immunoassay for detection of HIV is based on anti-HIV antibodies that recognize specific three-dimensional shapes in a massive, randomly generated library of synthetic peptoid molecules.

Investigators at the University of Pittsburgh School of Medicine (PA, USA) hypothesized that a random combinatorial library of synthetic poly-N-substituted glycine oligomers, or peptoids, could represent a random "shape library" in antigen space.

To test this theory, the investigators synthesized and screened a "one bead one compound" combinatorial library of peptoids, in which each bead displayed an eight-mer (repeating unit) peptoid with ten possible different amines at each position (108 theoretical variants). By screening one million peptoid beads the investigators found 112 (approximately one in 10,000) that preferentially bound immunoglobulins from human sera known to be positive for anti-HIV antibodies. Reactive peptoids were re-synthesized and rigorously evaluated in plate-based ELISA-style tests.

Results published in the May 12, 2016, online edition of the Journal of Immunological Methods revealed that four peptoids showed very good, and one showed excellent, properties for establishing a sero-diagnosis of HIV. These results demonstrated the feasibility of constructing sero-diagnostic assays for infectious diseases from libraries of random molecular shapes.

"This "needle-in-a-molecular haystack" approach is a new way to develop diagnostic assays," said senior author Dr. Donald S. Burke, director of the Center for Vaccine Research at the University of Pittsburgh School of Medicine. "The method does not rely on starting with known viral components. This is important because there are conditions for which there is not a known antigen, such as newly emerged epidemics, autoimmune diseases or even responses to traumatic injury."

"This technology means that we may be able to take a single drop of blood from a patient and detect antibodies to all manner of infections, cancers or other conditions they may be carrying or been exposed to," said Dr. Burke. "We hope that this is the first step toward development of an "Epi-chip" that can be used to reconstruct a person's entire exposure history."

Related Links:
University of Pittsburgh School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.